This week, Patheon has been showcasing the company’s fully integrated early development services at the 41st Annual Meeting & Exposition of the Controlled Release Society (CRS) at The Hilton Chicago in Chicago, Illinois, US.
It began on Saturday 12 July 12 and runs until Wednesday 16 July.
Solomon Kirsh, Arasu Kondappan, Enrico Corona, Paul Sabo and Sateesh Sathigari have been representing Patheon in leading five out of the nearly 750 poster and podium presentations offered at the CRS Annual Meeting & Exposition.
Solomon Kirsh, chemist at Patheon, has been presenting a poster detailing rapid HPLC method supporting renin inhibitor enteric coated beads formulation development; Arasu Kondappan, pharmaceutical formulation scientist at Patheon, will discuss the formulation of controlled release orally disintegrating tablets of water soluble compounds; and Enrico Corona, manager of formulation and process development at Patheon, has been presenting a poster on development of the manufacturing process for a parenteral depot formulation in the situ precipitation.
Posters such as those presented by experts at Patheon are used at the CRS Annual Meeting & Exposition to display scientific achievements and the newest technologies.
Podium presentations will include Stepwise Approach to Preformulation and Formulation Development to Maximize Clinical Success presented by Paul Sabo, senior specialist formulation at Patheon, and Production of Nano / Micro Drug Particles by Supercritical Fluid Technology led by Sateesh Sathigari, scientist of formulation and process development at Patheon.
Patheon, a gold sponsor of this year’s meeting, has also had a representative stationed at booth number 403 throughout the exposition.
The CRS Annual Meeting & Exposition is a professional, scientific meeting that will have more than 1,300 international scientists who work in drug delivery, consumer and diversified products in attendance.
The theme of this year’s CRS Annual Meeting & Exposition will be ‘Translation of Delivery Technology: Innovation to Commercialization’, and feature technology forums, soapbox sessions, industry roundtables and workshops where attendees can learn about pharmaceutical companies’ research, products and technology, and network with industry experts.